Screening tools to evaluate the neurotoxic potential of botanicals: building a strategy to assess safety

References

• Smith T, Resetar H, Morton C. US sales of herbal supplements increase by 9.7% in 2021. J Am Bot Counc. 2022:42–69. https://openurl.ebsco.com/EPDB%3Agcd%3A3%3A10824531/detailv2?sid=ebsco%3Aplink%3Ascholar&id=ebsco%3Agcd%3A161226031&crl=c
   Google Scholar
• Sorkin BC, Kuszak AJ, Bloss G, et al. Improving natural product research translation: from source to clinical trial. Faseb J. 2020;34(1):41–65. doi: 10.1096/fj.201902143R
   PubMed Web of Science ®Google Scholar
• Houriet J, Vidar WS, Manwill PK, et al. How low can you go? Selecting intensity thresholds for untargeted metabolomics data preprocessing. Anal Chem. 2022;94(51):17964–17971. doi: 10.1021/acs.analchem.2c04088
   PubMed Web of Science ®Google Scholar
• Klaassen CD, Casarett LJ, Doull J, editors. Casarett and Doull’s toxicology: the basic science of poisons. 8th ed. NY: McGraw-Hill Education; 2013.
   Google Scholar
• Programme international sur la sécurité des substances chimiques, editor. Neurotoxicity risk assessment for human health: principles and approaches. Geneva: World health organization; 2001.
   Google Scholar
• Giampreti A, Lonati D, Locatelli C, et al. Acute neurotoxicity after yohimbine ingestion by a body builder. Clin Toxicol. 2009;47(8):827–829. doi: 10.1080/15563650903081601
   Web of Science ®Google Scholar
• Guo J, Zhang J, Liu Q, et al. Research progress on components and mechanisms of neurotoxicity induced by traditional Chinese medicine. J Appl Toxicol. 2023;43(3):338–349. doi: 10.1002/jat.4396
   PubMed Web of Science ®Google Scholar
• Höllerhage M, Rösler TW, Berjas M, et al. Neurotoxicity of dietary supplements from annonaceae species. Int J Toxicol. 2015;34(6):543–550. doi: 10.1177/1091581815602252
   PubMed Web of Science ®Google Scholar
• Lüde S, Vecchio S, Sinno-Tellier S, et al. Adverse effects of plant food supplements and plants consumed as food: results from the poisons centres-based PlantLIBRA study. Phytother Res. 2016;30(6):988–996. doi: 10.1002/ptr.5604
   PubMed Web of Science ®Google Scholar
• Palmer VS, Tshala-Katumbay DD, Spencer PS. Plants with neurotoxic potential in undernourished subjects. Rev Neurol (Paris). 2019;175(10):631–640. doi: 10.1016/j.neurol.2019.07.015
   PubMed Web of Science ®Google Scholar
• Mitchell CA, Dever JT, Gafner S, et al. The botanical safety consortium: a public-private partnership to enhance the botanical safety toolkit. Regul Toxicol Pharmacol. 2022;128:105090. doi: 10.1016/j.yrtph.2021.105090
   PubMed Web of Science ®Google Scholar
• Botanical safety consortium – a public-private partnership to improve botanical safety [Internet]. [cited 2024 May 30]. Available from: https://botanicalsafetyconsortium.org/
   Google Scholar
• Behl M, Ryan K, Hsieh J-H, et al. Screening for developmental neurotoxicity at the national toxicology program: the future is here. Toxicological Sci. 2019;167(1):6–14. doi: 10.1093/toxsci/kfy278
   PubMed Web of Science ®Google Scholar
• Quiñonez-Silvero C, Hübner K, Herzog W. Development of the brain vasculature and the blood-brain barrier in zebrafish. Dev Biol. 2020;457(2):181–190. doi: 10.1016/j.ydbio.2019.03.005
   PubMed Web of Science ®Google Scholar
• Bauer B, Mally A, Liedtke D. Zebrafish embryos and larvae as alternative animal models for toxicity testing. IJMS. 2021;22(24):13417. doi: 10.3390/ijms222413417
   Google Scholar
• Cabrita A, Medeiros AM, Pereira T, et al. Motor dysfunction in drosophila melanogaster as a biomarker for developmental neurotoxicity. iScience. 2022;25(7):104541. doi: 10.1016/j.isci.2022.104541
   PubMed Web of Science ®Google Scholar
• Rand MD. Drosophotoxicology: the growing potential for drosophila in neurotoxicology. Neurotoxicol Teratol. 2010;32:74–83. doi: 10.1016/j.ntt.2009.06.004
   PubMed Web of Science ®Google Scholar
• Wallace K, Strickland JD, Valdivia P, et al. A multiplexed assay for determination of neurotoxicant effects on spontaneous network activity and viability from microelectrode arrays. Neurotoxicology. 2015;49:79–85. doi: 10.1016/j.neuro.2015.05.007
   PubMed Web of Science ®Google Scholar
• Johnstone AFM, Gross GW, Weiss DG, et al. Microelectrode arrays: a physiologically based neurotoxicity testing platform for the 21st century. Neurotoxicology. 2010;31(4):331–350. doi: 10.1016/j.neuro.2010.04.001
   PubMed Web of Science ®Google Scholar
• Robinette BL, Harrill JA, Mundy WR, et al. In vitro assessment of developmental neurotoxicity: use of microelectrode arrays to measure functional changes in neuronal network ontogeny. Front Neuroeng. 2011;4:1. doi: 10.3389/fneng.2011.00001
   PubMedGoogle Scholar
• McConnell ER, McClain MA, Ross J, et al. Evaluation of multi-well microelectrode arrays for neurotoxicity screening using a chemical training set. Neurotoxicology. 2012;33(5):1048–1057. doi: 10.1016/j.neuro.2012.05.001
   PubMed Web of Science ®Google Scholar
• Spira ME, Hai A. Multi-electrode array technologies for neuroscience and cardiology. Nat Nanotech. 2013;8(2):83–94. doi: 10.1038/nnano.2012.265
   PubMed Web of Science ®Google Scholar
• De Groot MWGDM, Westerink RHS, Dingemans MML. Don’t judge a neuron only by its cover: neuronal function in in vitro developmental neurotoxicity testing. Toxicological Sci. 2013;132:1–7. doi: 10.1093/toxsci/kfs269
   PubMed Web of Science ®Google Scholar
• Hogberg HT, Sobanski T, Novellino A, et al. Application of micro-electrode arrays (MEAs) as an emerging technology for developmental neurotoxicity: evaluation of domoic acid-induced effects in primary cultures of rat cortical neurons. Neurotoxicology. 2011;32(1):158–168. doi: 10.1016/j.neuro.2010.10.007
   PubMed Web of Science ®Google Scholar
• Valdivia P, Martin M, LeFew WR, et al. Multi-well microelectrode array recordings detect neuroactivity of ToxCast compounds. Neurotoxicology. 2014;44:204–217. doi: 10.1016/j.neuro.2014.06.012
   PubMed Web of Science ®Google Scholar
• Cotterill E, Hall D, Wallace K, et al. Characterization of early cortical neural network development in multi-well microelectrode array plates. SLAS Discov. 2016;21(5):510–519. doi: 10.1177/1087057116640520
   Google Scholar
• Mack CM, Lin BJ, Turner JD, et al. Burst and principal components analyses of MEA data for 16 chemicals describe at least three effects classes. Neurotoxicology. 2014;40:75–85. doi: 10.1016/j.neuro.2013.11.008
   PubMed Web of Science ®Google Scholar
• Dingemans MML, Schütte MG, Wiersma DMM, et al. Chronic 14-day exposure to insecticides or methylmercury modulates neuronal activity in primary rat cortical cultures. Neurotoxicology. 2016;57:194–202. doi: 10.1016/j.neuro.2016.10.002
   PubMed Web of Science ®Google Scholar
• Richardson JR, Fitsanakis V, Westerink RHS, et al. Neurotoxicity of pesticides. Acta Neuropathol. 2019;138(3):343–362. doi: 10.1007/s00401-019-02033-9
   PubMed Web of Science ®Google Scholar
• Kasteel EEJ, Westerink RHS. Comparison of the acute inhibitory effects of tetrodotoxin (TTX) in rat and human neuronal networks for risk assessment purposes. Toxicol Lett. 2017;270:12–16. doi: 10.1016/j.toxlet.2017.02.014
   PubMed Web of Science ®Google Scholar
• Tukker AM, Wijnolts FMJ, de Groot A, et al. Applicability of hiPSC-derived neuronal cocultures and rodent primary cortical cultures for in vitro seizure liability assessment. Toxicological Sci. 2020;178(1):71–87. doi: 10.1093/toxsci/kfaa136
   PubMed Web of Science ®Google Scholar
• Zwartsen A, Hondebrink L, Westerink RH. Neurotoxicity screening of new psychoactive substances (NPS): effects on neuronal activity in rat cortical cultures using microelectrode arrays (MEA). Neurotoxicology. 2018;66:87–97. doi: 10.1016/j.neuro.2018.03.007
   PubMed Web of Science ®Google Scholar
• Westerfield M. The zebrafish book. A guide for the laboratory use of zebrafish (danio rerio). 4th ed. Eugene (OR): University of Oregon Press; 2000.
   Google Scholar
• Kanungo J, Cuevas E, Ali S, et al. Zebrafish model in drug safety assessment. CPD. 2014;20(34):5416–5429. doi: 10.2174/1381612820666140205145658
   Google Scholar
• Ablain J, Zon LI. Fish and men: using zebrafish to fight human diseases. Trends Cell Biol. 2013;23(12):584–586. doi: 10.1016/j.tcb.2013.09.009
   PubMed Web of Science ®Google Scholar
• Howe K, Clark MD, Torroja CF, et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature. 2013;496(7446):498–503. doi: 10.1038/nature12111
   PubMed Web of Science ®Google Scholar
• Nawaji T, Yamashita N, Umeda H, et al. Cytochrome P450 expression and chemical metabolic activity before full liver development in zebrafish. Pharmaceuticals. 2020;13(12):456. doi: 10.3390/ph13120456
   Web of Science ®Google Scholar
• d’Amora M, Giordani S. The utility of zebrafish as a model for screening developmental neurotoxicity. Front Neurosci. 2018;12:976. doi: 10.3389/fnins.2018.00976
   PubMed Web of Science ®Google Scholar
• Horzmann KA, Freeman JL. Making waves: new developments in toxicology with the zebrafish. Toxicological Sci. 2018;163(1):5–12. doi: 10.1093/toxsci/kfy044
   PubMed Web of Science ®Google Scholar
• Kalueff AV, editor. The rights and wrongs of zebrafish: behavioral phenotyping of zebrafish [internet]. Cham: Springer International Publishing; 2017 [cited 2023 Oct 19]. doi: 10.1007/978-3-319-33774-6
   Google Scholar
• Reif DM, Truong L, Mandrell D, et al. High-throughput characterization of chemical-associated embryonic behavioral changes predicts teratogenic outcomes. Arch Toxicol. 2016;90(6):1459–1470. doi: 10.1007/s00204-015-1554-1
   PubMed Web of Science ®Google Scholar
• Kalueff AV, Gebhardt M, Stewart AM, et al. Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond. Zebrafish. 2013;10(1):70–86. doi: 10.1089/zeb.2012.0861
   PubMed Web of Science ®Google Scholar
• MacPhail RC, Brooks J, Hunter DL, et al. Locomotion in larval zebrafish: influence of time of day, lighting and ethanol. Neurotoxicology. 2009;30(1):52–58. doi: 10.1016/j.neuro.2008.09.011
   PubMed Web of Science ®Google Scholar
• López-Schier H. Neuroplasticity in the acoustic startle reflex in larval zebrafish. Curr Opin Neurobiol. 2019;54:134–139. doi: 10.1016/j.conb.2018.10.004
   PubMed Web of Science ®Google Scholar
• Burgess HA, Granato M. Sensorimotor gating in larval zebrafish. J Neurosci. 2007;27(18):4984–4994. doi: 10.1523/JNEUROSCI.0615-07.2007
   PubMed Web of Science ®Google Scholar
• Zhang S, Li F, Zhou T, et al. Caenorhabditis elegans as a useful model for studying aging mutations. Front Endocrinol. 2020;11:554994. doi: 10.3389/fendo.2020.554994
   PubMed Web of Science ®Google Scholar
• Leung MCK, Williams PL, Benedetto A, et al. Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicological Sci. 2008;106(1):5–28. doi: 10.1093/toxsci/kfn121
   PubMed Web of Science ®Google Scholar
• Sammi SR, Jameson LE, Conrow KD, et al. Caenorhabditis elegans neurotoxicity testing: novel applications in the adverse outcome pathway framework. Front Toxicol. 2022;4:826488. doi: 10.3389/ftox.2022.826488
   PubMedGoogle Scholar
• Martins AC, Gubert P, Li J, et al. Caenorhabditis elegans as a model to study manganese-induced neurotoxicity. Biomolecules. 2022;12(10):1396. doi: 10.3390/biom12101396
   PubMed Web of Science ®Google Scholar
• Hart AB. WormBook: the online review of C elegans biology [internet] [internet]. WormBook. 2006 [cited 2023 Oct 19]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK19734/
   Google Scholar
• Ruszkiewicz JA, Pinkas A, Miah MR, et al. C. elegans as a model in developmental neurotoxicology. Toxicol Appl Pharmacol. 2018;354:126–135. doi: 10.1016/j.taap.2018.03.016
   PubMed Web of Science ®Google Scholar
• White JG, Southgate E, Thomson JN, et al. The structure of the nervous system of the nematode Caenorhabditis elegans. Philos Trans R Soc Lond B Biol Sci. 1986;314:1–340.
   PubMed Web of Science ®Google Scholar
• Barclay JW, Morgan A, Burgoyne RD. Neurotransmitter release mechanisms studied in Caenorhabditis elegans. Cell Calcium. 2012;52(3–4):289–295. doi: 10.1016/j.ceca.2012.03.005
   PubMed Web of Science ®Google Scholar
• Brownlee DJA, Fairweather I. Exploring the neurotransmitter labyrinth in nematodes. Trends Neurosci. 1999;22(1):16–24. doi: 10.1016/S0166-2236(98)01281-8
   PubMed Web of Science ®Google Scholar
• Bargmann CI. Neurobiology of the Caenorhabditis elegans genome. Science. 1998;282(5396):2028–2033. doi: 10.1126/science.282.5396.2028
   PubMed Web of Science ®Google Scholar
• Goodman MB, Hall DH, Avery L, et al. Active currents regulate sensitivity and dynamic range in C. elegans neurons. Neuron. 1998;20(4):763–772. doi: 10.1016/S0896-6273(00)81014-4
   PubMed Web of Science ®Google Scholar
• Waidyanatha S, Collins BJ, Cristy T, et al. Advancing botanical safety: a strategy for selecting, sourcing, and characterizing botanicals for developing toxicological tools. Food Chem Toxicol. 2024;186:114537. doi: 10.1016/j.fct.2024.114537
   PubMed Web of Science ®Google Scholar
• Li S, Yu L, Shi Q, et al. An insight into current advances on pharmacology, pharmacokinetics, toxicity and detoxification of aconitine. Biomed Pharmacother. 2022;151:113115. doi: 10.1016/j.biopha.2022.113115
   PubMed Web of Science ®Google Scholar
• Gao X, Hu J, Zhang X, et al. Research progress of aconitine toxicity and forensic analysis of aconitine poisoning. Forensic Sci Res. 2020;5(1):25–31. doi: 10.1080/20961790.2018.1452346
   PubMedGoogle Scholar
• Pullela R, Young L, Gallagher B, et al. A case of fatal aconitine poisoning by monkshood ingestion. J Forensic Sci. 2008;53(2):491–494. doi: 10.1111/j.1556-4029.2007.00647.x
   PubMed Web of Science ®Google Scholar
• Strzelecki A, Pichon N, Gaulier JM, et al. Acute toxic herbal intake in a suicide attempt and fatal refractory ventricular arrhythmia. Basic Clin Pharmacol Toxicol. 2010;107(2):698–699. doi: 10.1111/j.1742-7843.2010.00566.x
   PubMed Web of Science ®Google Scholar
• Feldkamp A, Köster B, Weber HP. [Fatal poisoning caused by aconite monk’s hood (Aconitum napellus)]. Monatsschr Kinderheilkd. 1991;139(6):366–367.
   PubMed Web of Science ®Google Scholar
• Povšnar M, Koželj G, Kreft S, et al. Rare tradition of the folk medicinal use of Aconitum spp. is kept alive in Solčavsko, Slovenia. J Ethnobiol Ethnomed. 2017;13(1):45. doi: 10.1186/s13002-017-0171-x
   PubMedGoogle Scholar
• Zhao X, Ni S, Liang N, et al. Clinical application of Aconitum carmichaelii Debx. (Fu Zi in Chinese) by traditional Chinese medicine physicians--A cross-sectional questionnaire survey in Beijing. J Tradit Chin Med Sci. 2021;8(4):302–308. doi: 10.1016/j.jtcms.2021.10.008
   Google Scholar
• Sun W, Yan B, Wang R, et al. In vivo acute toxicity of detoxified Fuzi (lateral root of Aconitum carmichaeli) after a traditional detoxification process. EXCLI J. 2018 [cited 2024 Feb 7];17:Doc889. [Internet]. Available from: https://www.excli.de/vol17/Huang_31082018_proof.pdf
   Web of Science ®Google Scholar
• Chung JY, Lee SJ, Lee HJ, et al. Aconitine neurotoxicity according to administration methods. JCM. 2021;10(10):2149. doi: 10.3390/jcm10102149
   Google Scholar
• Lin C-C, Chan TYK, Deng J-F. Clinical features and management of herb-induced aconitine poisoning. Ann Emerg Med. 2004;43(5):574–579. doi: 10.1016/j.annemergmed.2003.10.046
   PubMed Web of Science ®Google Scholar
• Li T-F, Fan H, Wang Y-X. Aconitum-derived bulleyaconitine a exhibits antihypersensitivity through direct stimulating dynorphin a expression in spinal microglia. The J Pain. 2016;17(5):530–548. doi: 10.1016/j.jpain.2015.12.015
   PubMed Web of Science ®Google Scholar
• Wang S. Voltage-gated sodium channels as primary targets of diverse lipid-soluble neurotoxins. Cell Signal. 2003;15(2):151–159. doi: 10.1016/S0898-6568(02)00085-2
   PubMed Web of Science ®Google Scholar
• Chan TYK. Aconite poisoning. Clin Toxicol. 2009;47(4):279–285. doi: 10.1080/15563650902904407
   Web of Science ®Google Scholar
• Nyirimigabo E, Xu Y, Li Y, et al. A review on phytochemistry, pharmacology and toxicology studies of Aconitum. J Pharm and Pharmacol. 2014;67(1):1–19. doi: 10.1111/jphp.12310
   PubMed Web of Science ®Google Scholar
• Chen H, Wang F, Ni X, et al. Aconitine disrupts serotonin neurotransmission via 5‐hydroxytryptamine receptor in zebrafish embryo. J Appl Toxicol. 2021;41(3):483–492. doi: 10.1002/jat.4059
   PubMed Web of Science ®Google Scholar
• Zhou J, Peng C, Li Q, et al. Dopamine homeostasis imbalance and dopamine receptors-mediated AC/cAMP/PKA pathway activation are involved in aconitine-induced neurological impairment in zebrafish and SH-SY5Y cells. Front Pharmacol. 2022;13:837810. doi: 10.3389/fphar.2022.837810
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen S, Fan F, et al. Neurotoxicity mechanism of aconitine in HT22 cells studied by microfluidic chip-mass spectrometry. J Pharm Anal. 2023;13(1):88–98. doi: 10.1016/j.jpha.2022.11.007
   PubMed Web of Science ®Google Scholar
• Ameri A. The effects of aconitum alkaloids on the central nervous system. Prog Neurobiol. 1998;56(2):211–235. doi: 10.1016/S0301-0082(98)00037-9
   PubMed Web of Science ®Google Scholar
• Debelle FD, Vanherweghem J-L, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Int. 2008;74(2):158–169. doi: 10.1038/ki.2008.129
   PubMed Web of Science ®Google Scholar
• Grady D. Chinese herb is suspected in cancer. The New York Times [Internet]. 2000 Jun 8 [cited 2023 Oct 19]. Available from: https://www.nytimes.com/2000/06/08/us/chinese-herb-is-suspected-in-cancer.html
   Google Scholar
• Shang X, You C, Li X, et al. Involvement of 5-HT2 serotonin receptors in cognitive defects induced by aristolochic acid I in mice. Toxicology. 2021;447:152624. doi: 10.1016/j.tox.2020.152624
   PubMed Web of Science ®Google Scholar
• Chen J, Kong A, Shelton D, et al. Early life stage transient aristolochic acid exposure induces behavioral hyperactivity but not nephrotoxicity in larval zebrafish. Aquat Toxicol. 2021;238:105916. doi: 10.1016/j.aquatox.2021.105916
   PubMed Web of Science ®Google Scholar
• Speers AB, Cabey KA, Soumyanath A, et al. Effects of Withania somnifera (Ashwagandha) on stress and the stress- related neuropsychiatric disorders anxiety, depression, and insomnia. CN. 2021;19(9):1468–1495. doi: 10.2174/1570159X19666210712151556
   Google Scholar
• Lubarska M, Hałasiński P, Hryhorowicz S, et al. Liver dangers of herbal products: a case report of Ashwagandha-induced liver injury. Int J Environ Res Public Health. 2023;20(5):3921. doi: 10.3390/ijerph20053921
   PubMedGoogle Scholar
• Siddiqui S, Ahmed N, Goswami M, et al. DNA damage by Withanone as a potential cause of liver toxicity observed for herbal products of Withania somnifera (Ashwagandha). Curr Res Toxicol. 2021;2:72–81. doi: 10.1016/j.crtox.2021.02.002
   PubMedGoogle Scholar
• Durg S, Dhadde SB, Vandal R, et al. Withania somnifera (Ashwagandha) in neurobehavioural disorders induced by brain oxidative stress in rodents: a systematic review and meta-analysis. J Pharm and Pharmacol. 2015;67(7):879–899. doi: 10.1111/jphp.12398
   PubMed Web of Science ®Google Scholar
• Zahiruddin S, Basist P, Parveen A, et al. Ashwagandha in brain disorders: A review of recent developments. J Ethnopharmacol. 2020;257:112876. doi: 10.1016/j.jep.2020.112876
   PubMed Web of Science ®Google Scholar
• Asian Ginseng. U.S. National Center for Complementary and Integrative Health. [Internet]. [cited 2023 Oct 19]. Available from: https://www.nccih.nih.gov/health/asian-ginseng
   Google Scholar
• Jin T-Y, Rong P-Q, Liang H-Y, et al. Clinical and preclinical systematic review of Panax ginseng C. A. Mey and its compounds for fatigue. Front Pharmacol. 2020;11:1031. doi: 10.3389/fphar.2020.01031
   PubMed Web of Science ®Google Scholar
• Zheng Q-L, Zhu H-Y, Xu X, et al. Korean red ginseng alleviate depressive disorder by improving astrocyte gap junction function. J Ethnopharmacol. 2021;281:114466. doi: 10.1016/j.jep.2021.114466
   PubMed Web of Science ®Google Scholar
• Petkov VD, Belcheva S, Petkov VV. Behavioral effects of Ginkgo biloba L. Panax ginseng C.A. Mey. and Gincosan®. Am J Chin Med. 2003;31(6):841–855. doi: 10.1142/S0192415X03001533
   PubMed Web of Science ®Google Scholar
• National Toxicology Program. Toxicology and carcinogenesis studies of ginseng (CAS No. 50647-08-0) in F344/N rats and B6C3F1 mice (gavage studies). Natl Toxicol Program Tech Rep Ser. 2011:1–149.
   Google Scholar
• Kuo Y-H, Ikegami F, Lambein F. Neuroactive and other free amino acids in seed and young plants of panax ginseng. Phytochemistry. 2003;62(7):1087–1091. doi: 10.1016/S0031-9422(02)00658-1
   PubMed Web of Science ®Google Scholar
• Long Y, Ye Y, Xing Q. Studies on the neuroexcitotoxin β‐ N ‐oxalo‐L‐α, β‐diaminopropionic acid and its isomer α‐ N ‐oxalo‐L‐α, βdiaminopropionic acid from the root of Panax species. Int J Peptide and Protein Res. 1996;47(1–2):42–46. doi: 10.1111/j.1399-3011.1996.tb00808.x
   PubMedGoogle Scholar
• National Toxicology Program (NTP). Botanical Safety Consortium – Chemical Analysis [Internet]. 2023 [cited 2024 Feb 7]. p. 500–007–001–000–003. Available from: https://cebs.niehs.nih.gov/cebs/paper/15717
   Google Scholar
• Datta S, Mahdi F, Ali Z, et al. Toxins in botanical dietary supplements: blue cohosh components disrupt cellular respiration and mitochondrial membrane potential. J Nat Prod. 2014;77(1):111–117. doi: 10.1021/np400758t
   PubMed Web of Science ®Google Scholar
• Schep LJ, Slaughter RJ, Beasley DMG. Nicotinic plant poisoning. Clin Toxicol. 2009;47(8):771–781. doi: 10.1080/15563650903252186
   PubMed Web of Science ®Google Scholar
• Slater Y. Halogenated cytisine derivatives as agonists at human neuronal nicotinic acetylcholine receptor subtypes. Neuropharmacology. 2003;44(4):503–515. doi: 10.1016/S0028-3908(03)00025-X
   PubMed Web of Science ®Google Scholar
• Green BT, Lee ST, Panter KE, et al. Actions of piperidine alkaloid teratogens at fetal nicotinic acetylcholine receptors. Neurotoxicol Teratol. 2010;32(3):383–390. doi: 10.1016/j.ntt.2010.01.011
   PubMed Web of Science ®Google Scholar
• Wei X, Ruan W, Vrieling K. Current knowledge and perspectives of pyrrolizidine alkaloids in pharmacological applications: a mini-review. Molecules. 2021;26(7):1970. doi: 10.3390/molecules26071970
   PubMed Web of Science ®Google Scholar
• Schramm S, Köhler N, Rozhon W. Pyrrolizidine alkaloids: Biosynthesis, biological activities and occurrence in crop plants. Molecules. 2019;24:498. doi: 10.3390/molecules24030498
   PubMed Web of Science ®Google Scholar
• Verma V, Singh N, Jaggi AS. Sodium-hydrogen exchanger inhibitory potential of Malus domestica , Musa × paradisiaca , Daucus carota , and Symphytum officinale. J Basic Clin Physiol Pharmacol [Internet]. 2014 [cited 2023 Oct 19];25(1):99–108. Available from: https://www.degruyter.com/document/doi/10.1515/jbcpp-2013-0088/html
   PubMedGoogle Scholar
• Chesler M. Regulation and modulation of pH in the brain. Physiol Rev. 2003;83(4):1183–1221. doi: 10.1152/physrev.00010.2003
   PubMed Web of Science ®Google Scholar
• Hwang S-M, Koo N-Y, Jin M, et al. Intracellular acidification is associated with changes in free cytosolic calcium and inhibition of action potentials in rat trigeminal ganglion. J Biol Chem. 2011;286(3):1719–1729. doi: 10.1074/jbc.M109.090951
   PubMed Web of Science ®Google Scholar
• Pavlov I, Kaila K, Kullmann DM, et al. Cortical inhibition, pH and cell excitability in epilepsy: what are optimal targets for antiepileptic interventions?: cortical inhibition, pH and cell excitability in epilepsy. J Physiol. 2013;591(4):765–774. doi: 10.1113/jphysiol.2012.237958
   PubMed Web of Science ®Google Scholar
• Uria-Avellanal C, Robertson NJ. Na+/H+ exchangers and intracellular ph in perinatal brain injury. Transl Stroke Res. 2014;5(1):79–98. doi: 10.1007/s12975-013-0322-x
   PubMed Web of Science ®Google Scholar
• LiverTox: Clinical and research Information on drug-induced liver injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012 [cited 2023 Oct 19]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK547852/
   Google Scholar
• Ephedra. NCCIH. [Internet]. [cited 2023 Oct 19]. Available from: https://www.nccih.nih.gov/health/ephedra
   Google Scholar
• Food, Drug Administration HHS. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule Fed Regist. 2004;69:6787–6854.
   PubMedGoogle Scholar
• Shekelle PG, Hardy ML, Morton SC, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA. 2003;289(12):1537–1545. doi: 10.1001/jama.289.12.1537
   PubMed Web of Science ®Google Scholar
• Office of Dietary Supplements - Ephedra and Ephedrine Alkaloids for Weight Loss and Athletic Performance [Internet]. [cited 2023 Nov 30]. Available from: https://ods.od.nih.gov/factsheets/EphedraandEphedrine-HealthProfessional/
   Google Scholar
• Moawad FJ, Hartzell JD, Biega TJ, et al. Transient blindness due to posterior reversible encephalopathy syndrome following ephedra overdose. South Med J. 2006;99(5):511–514. doi: 10.1097/01.smj.0000215739.90211.3b
   PubMed Web of Science ®Google Scholar
• Vukovich MD, Schoorman R, Heilman C, et al. Caffeine–herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure. Clin Exp Pharmacol Physiol. 2005;32(1–2):47–53. doi: 10.1111/j.1440-1681.2005.04152.x
   PubMed Web of Science ®Google Scholar
• Zheng F, Wei P, Huo H, et al. Neuroprotective effect of gui zhi (Ramulus Cinnamomi) on ma huang- (Herb Ephedra-) Induced toxicity in rats treated with a ma huang-gui zhi herb pair. Evidence-Based Complementary and Alternative Med. 2015;2015:1–9. doi: 10.1155/2015/913461
   Web of Science ®Google Scholar
• Niu B, Zheng F, Xu J. Protective effect of gui zhi (Ramulus Cinnamomi) on abnormal levels of four amino acid neurotransmitters by chronically ma huang (Herb Ephedra) intoxicated prefrontal cortex in rats treated with a ma huang-gui zhi herb pair. J Ethnopharmacol. 2020;249:112408. doi: 10.1016/j.jep.2019.112408
   PubMed Web of Science ®Google Scholar
• Dawson P, Moffatt JD. Cardiovascular toxicity of novel psychoactive drugs: Lessons from the past. Prog Neuro-Psychopharmacol Biol Psychiatry. 2012;39(2):244–252. doi: 10.1016/j.pnpbp.2012.05.003
   PubMed Web of Science ®Google Scholar
• Bowyer JF. An evaluation of l-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamate. Toxicological Sci. 2000;55(1):133–142. doi: 10.1093/toxsci/55.1.133
   PubMed Web of Science ®Google Scholar
• Calvert R, Vohra S, Ferguson M, et al. A beating heart cell model to predict cardiotoxicity: Effects of the dietary supplement ingredients higenamine, phenylethylamine, ephedrine and caffeine. Food Chem Toxicol. 2015;78:207–213. doi: 10.1016/j.fct.2015.01.022
   PubMed Web of Science ®Google Scholar
• Zuo S, Li W, Li Q, et al. Protective effects of Ephedra sinica extract on blood–brain barrier integrity and neurological function correlate with complement C3 reduction after subarachnoid hemorrhage in rats. Neurosci Lett. 2015;609:216–222. doi: 10.1016/j.neulet.2015.10.056
   PubMed Web of Science ®Google Scholar
• Green Tea. U.S. National Center for Complementary and Integrative Health. [Internet]. [cited 2023 Oct 20]. Available from: https://www.nccih.nih.gov/health/green-tea
   Google Scholar
• Prasanth M, Sivamaruthi B, Chaiyasut C, et al. A review of the role of green tea (camellia sinensis) in antiphotoaging, stress resistance, neuroprotection, and autophagy. Nutrients. 2019;11(2):474. doi: 10.3390/nu11020474
   PubMed Web of Science ®Google Scholar
• National Toxicology Program. Toxicology studies of green tea extract in F344/NTac rats and B6C3F1/N mice and toxicology and carcinogenesis studies of green tea extract in Wistar Han [Crl:WI(Han)] rats and B6C3F1/N mice (gavage studies). Natl Toxicol Program Tech Rep Ser. 2016:1–238.
   Google Scholar
• Oketch-Rabah HA, Roe AL, Rider CV, et al. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts. Toxicol Rep. 2020;7:386–402. doi: 10.1016/j.toxrep.2020.02.008
   PubMed Web of Science ®Google Scholar
• Lovera J, Ramos A, Devier D, et al. Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: phase I single group and phase II randomized placebo-controlled studies. J Neurol Sci. 2015;358(1–2):46–52. doi: 10.1016/j.jns.2015.08.006
   PubMed Web of Science ®Google Scholar
• National Toxicology Program. Toxicology and carcinogenesis studies of goldenseal root powder (Hydrastis canadensis) in F344/N rats and B6C3F1 mice (feed studies). Natl Toxicol Program Tech Rep Ser. 2010:1–188.
   Google Scholar
• Mandal SK, Maji AK, Mishra SK, et al. Goldenseal (Hydrastis canadensis L.) and its active constituents: A critical review of their efficacy and toxicological issues. Pharmacol Res. 2020;160:105085. doi: 10.1016/j.phrs.2020.105085
   PubMed Web of Science ®Google Scholar
• Yin SY, Lee JJ, Kim YM, et al. Effects of (1R,9S)-β-hydrastine on l-DOPA-induced cytotoxicity in PC12 cells. Eur J Pharmacol. 2004;488(1–3):71–77. doi: 10.1016/j.ejphar.2004.02.021
   PubMed Web of Science ®Google Scholar
• Kim SH, Shin JS, Lee JJ, et al. Effects of hydrastine derivatives on dopamine biosynthesis in PC12 cells. Planta Med. 2001;67(7):609–613. doi: 10.1055/s-2001-17356
   PubMed Web of Science ®Google Scholar
• Kysenius K, Brunello CA, Huttunen HJ, et al. Mitochondria and NMDA receptor-dependent toxicity of berberine sensitizes neurons to glutamate and rotenone injury. Tang S-J, editor. PLOS ONE. 2014;9(9):e107129. doi: 10.1371/journal.pone.0107129
   PubMed Web of Science ®Google Scholar
• Senol Deniz FS, Ekhteiari Salmas R, Emerce E, et al. Cholinesterase inhibitory and in silico toxicity assessment of thirty-four isoquinoline alkaloids - berberine as the lead compound. CNS Neurol Disord Drug Targets. 2023;23(6):773–783. doi: 10.2174/1871527322666230417083053
   Web of Science ®Google Scholar
• Kulkarni SK, Dhir A. Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res. 2010;24(3):317–324. doi: 10.1002/ptr.2968
   PubMed Web of Science ®Google Scholar
• Zhang R, Lei B, Wu G, et al. Protective effects of berberine against β-amyloid-induced neurotoxicity in HT22 cells via the Nrf2/HO‐1 pathway. Bioorg Chem. 2023;133:106210. doi: 10.1016/j.bioorg.2022.106210
   PubMed Web of Science ®Google Scholar
• Goldenseal. Drugs and Lactation Database (LactMed®). [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006 [cited 2023 Oct 20]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK501866/
   Google Scholar
• Babu KM, McCurdy CR, Boyer EW. Opioid receptors and legal highs: Salvia divinorum and Kratom. Clin Toxicol (Phila). 2008;46:146–152. doi: 10.1080/15563650701241795
   PubMed Web of Science ®Google Scholar
• Garcia-Romeu A, Cox DJ, Smith KE, et al. Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic. Drug Alcohol Depend. 2020;208:107849. doi: 10.1016/j.drugalcdep.2020.107849
   PubMed Web of Science ®Google Scholar
• Office of the Commissioner. FDA and Kratom [Internet]. FDA. 2023 [cited 2023 Nov 29]. Available from: https://www.fda.gov/news-events/public-health-focus/fda-and-kratom
   Google Scholar
• Anand A, Hosanagar A. The addictive potential and challenges with use of the “herbal supplement” kratom: a case report and literature review. Pain Med. 2022;23(1):4–9. doi: 10.1093/pm/pnab126
   PubMed Web of Science ®Google Scholar
• Hossain R, Sultana A, Nuinoon M, et al. A critical review of the neuropharmacological effects of kratom: an insight from the functional array of identified natural compounds. Molecules. 2023;28(21):7372. doi: 10.3390/molecules28217372
   PubMed Web of Science ®Google Scholar
• Hassan Z, Singh D, Suhaimi FW, et al. Evaluation of toxicity profile of kratom (Mitragyna speciosa Korth) decoction in rats. Regul Toxicol Pharmacol. 2023;143:105466. doi: 10.1016/j.yrtph.2023.105466
   PubMed Web of Science ®Google Scholar
• Suhaimi FW, Zul Aznal AN, Mohamad nor Hazalin NA, et al. Kratom (M. speciosa) exposure during adolescence caused long-lasting cognitive behavioural deficits associated with perturbated brain metabolism pathways in adult rats. Behav Brain Res. 2023;446:114411. doi: 10.1016/j.bbr.2023.114411
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Horie S, Takayama H, et al. Antinociception, tolerance and withdrawal symptoms induced by 7-hydroxymitragynine, an alkaloid from the Thai medicinal herb Mitragyna speciosa. Life Sci. 2005;78(1):2–7. doi: 10.1016/j.lfs.2004.10.086
   PubMed Web of Science ®Google Scholar
• Basheer M, Hassan Z, Gam L-H. Upregulation of brain’s calcium binding proteins in mitragynine dependence: a potential cellular mechanism to addiction. Int J Med Sci. 2023;20(1):102–113. doi: 10.7150/ijms.78861
   PubMed Web of Science ®Google Scholar
• Suhaimi FW, Yusoff NHM, Hassan R, et al. Neurobiology of Kratom and its main alkaloid mitragynine. Brain Res Bull. 2016;126:29–40. doi: 10.1016/j.brainresbull.2016.03.015
   PubMed Web of Science ®Google Scholar
• Karunakaran T, Ngew KZ, Zailan AAD, et al. The chemical and pharmacological properties of mitragynine and its diastereomers: An insight review. Front Pharmacol. 2022;13:805986. doi: 10.3389/fphar.2022.805986
   PubMed Web of Science ®Google Scholar
• Viwatpinyo K, Mukda S, Warinhomhoun S. Effects of mitragynine on viability, proliferation, and migration of C6 rat glioma, SH-SY5Y human neuroblastoma, and HT22 immortalized mouse hippocampal neuron cell lines. Biomed Pharmacother. 2023;166:115364. doi: 10.1016/j.biopha.2023.115364
   PubMed Web of Science ®Google Scholar
• Effendy MA, Yunusa S, Mat NH, et al. The role of AMPA and NMDA receptors in mitragynine effects on hippocampal synaptic plasticity. Behav Brain Res. 2023;438:114169. doi: 10.1016/j.bbr.2022.114169
   PubMed Web of Science ®Google Scholar
• Moragrega I, Ríos JL. Medicinal plants in the treatment of depression. II: evidence from clinical trials. Planta Med. 2022;88(12):1092–1110. doi: 10.1055/a-1517-6882
   PubMed Web of Science ®Google Scholar
• National Toxicology Program. Toxicology and carcinogenesis studies of kava kava extract (CAS No. 9000-38-8) in F344/N rats and B6C3F1 mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser. 2012:1–186.
   Google Scholar
• Wang Y, Su C, Zhang B, et al. Biological activity, hepatotoxicity, and structure-activity relationship of kavalactones and flavokavins, the two main bioactive components in Kava (Piper methysticum). Evid Based Complement Alternat Med. 2021;2021:1–14. doi: 10.1155/2021/6851798
   Web of Science ®Google Scholar
• Romm AJ, Kava K. Botanical medicine for women’s health. St Louis (Mo): Churchill Livingstone/Elsevier; 2010. p. 539–541.
   Google Scholar
• Kautu BB, Phillips J, Steele K, et al. A behavioral survey of the effects of kavalactones on Caenorhabditis elegans neuromuscular transmission. J Exp Neurosci. 2017;11:117906951770538. doi: 10.1177/1179069517705384
   Google Scholar
• Krum BN, de Freitas CM, Busanello A, et al. Ex vivo and in vitro inhibitory potential of kava extract on monoamine oxidase B activity in mice. J Tradit Complement Med. 2022;12(2):115–122. doi: 10.1016/j.jtcme.2021.07.002
   PubMedGoogle Scholar
• Sub Laban T, Saadabadi A. Monoamine Oxidase Inhibitors (MAOI). StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Oct 20]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK539848/
   Google Scholar
• Konradi C, Riederer P, Jellinger K, et al. Cellular action of MAO inhibitors. J Neural Transm Suppl. 1987;25:15–25.
   PubMedGoogle Scholar
• Riederer P, Laux G. MAO-inhibitors in Parkinson’s disease. Exp Neurobiol. 2011;20(1):1–17. doi: 10.5607/en.2011.20.1.1
   PubMedGoogle Scholar
• Schelosky L, Raffauf C, Jendroska K, et al. Kava and dopamine antagonism. J Neurol Neurosurg & Psychiatry. 1995;58(5):639–640. doi: 10.1136/jnnp.58.5.639
   PubMed Web of Science ®Google Scholar
• Bijak M. Silybin, a major bioactive component of milk thistle (Silybum marianum L. Gaernt.)—chemistry, bioavailability, and metabolism. Molecules. 2017;22(11):1942. doi: 10.3390/molecules22111942
   PubMed Web of Science ®Google Scholar
• Blumenthal M, Busse WR; Bundesinstitut für Arzneimittel und Medizinprodukte (Germany), editors. The complete German Commission E monographs. Therapeutic guide to herbal medicines. Austin (TX): boston: American Botanical Council; Integrative Medicine Communications; 1998.
   Google Scholar
• National Toxicology Program. Toxicology and carcinogenesis studies of milk thistle extract (CAS No. 84604-20-6) in F344/N rats and B6C3F1 mice (feed studies). Natl Toxicol Program Tech Rep Ser. 2011:1–177.
   Google Scholar
• Lu C-W, Lin T-Y, Chiu K-M, et al. Silymarin inhibits glutamate release and prevents against kainic acid-induced excitotoxic injury in rats. Biomedicines. 2020;8(11):486. doi: 10.3390/biomedicines8110486
   PubMed Web of Science ®Google Scholar
• Xie Z, Ding S, Shen Y. Silibinin activates AMP-activated protein kinase to protect neuronal cells from oxygen and glucose deprivation-re-oxygenation. Biochem Biophys Res Commun. 2014;454(2):313–319. doi: 10.1016/j.bbrc.2014.10.080
   PubMed Web of Science ®Google Scholar
• Duan S, Guan X, Lin R, et al. Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for the treatment of Alzheimer’s disease. Neurobiol Aging. 2015;36(5):1792–1807. doi: 10.1016/j.neurobiolaging.2015.02.002
   PubMed Web of Science ®Google Scholar
• Fanoudi S, Alavi MS, Karimi G, et al. Milk thistle (Silybum Marianum) as an antidote or a protective agent against natural or chemical toxicities: a review. Drug Chem Toxicol. 2020;43(3):240–254. doi: 10.1080/01480545.2018.1485687
   PubMed Web of Science ®Google Scholar
• Haddadi R, Shahidi Z, Eyvari-Brooshghalan S. Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms. Phytomedicine. 2020;79:153320. doi: 10.1016/j.phymed.2020.153320
   PubMed Web of Science ®Google Scholar
• Devi KP, Malar DS, Braidy N, et al. A mini review on the chemistry and neuroprotective effects of silymarin. Curr Drug Targets. 2017;18(13):1529–1536. doi: 10.2174/1389450117666161227125121
   PubMed Web of Science ®Google Scholar
• Nerium oleander L.(PIM 366) [Internet]. [cited 2023 Oct 20]. Available from: https://inchem.org/documents/pims/plant/pim366.htm#SectionTitle:1.3%20%20Common%20name(s)%20and%20synonyms
   Google Scholar
• Zhai J, Dong X, Yan F, et al. Oleandrin: A systematic review of its natural sources, structural properties, detection methods, pharmacokinetics and toxicology. Front Pharmacol. 2022;13:822726. doi: 10.3389/fphar.2022.822726
   PubMed Web of Science ®Google Scholar
• Azzalini E, Bernini M, Vezzoli S, et al. A fatal case of self-poisoning through the ingestion of oleander leaves. J Forensic Leg Med. 2019;65:133–136. doi: 10.1016/j.jflm.2019.05.016
   PubMed Web of Science ®Google Scholar
• Pietsch J, Oertel R, Trautmann S, et al. A non-fatal oleander poisoning. Int J Legal Med. 2005;119(4):236–240. doi: 10.1007/s00414-005-0548-6
   PubMed Web of Science ®Google Scholar
• Carfora A, Petrella R, Borriello R, et al. Fatal poisoning by ingestion of a self-prepared oleander leaf infusion. Forensic Sci Med Pathol. 2021;17(1):120–125. doi: 10.1007/s12024-020-00338-w
   PubMed Web of Science ®Google Scholar
• Bavunoglu I, Balta M, Turkmen Z. Oleander poisoning as an example of self-medication attempt. Balkan Med J. 2016;33(5):559–562. doi: 10.5152/balkanmedj.2016.150307
   PubMed Web of Science ®Google Scholar
• Farkhondeh T, Kianmehr M, Kazemi T, et al. Toxicity effects of Nerium oleander, basic and clinical evidence: a comprehensive review. Hum Exp Toxicol. 2020;39(6):773–784. doi: 10.1177/0960327120901571
   PubMed Web of Science ®Google Scholar
• Moseley AE, Williams MT, Schaefer TL, et al. Deficiency in Na,K-ATPase α isoform genes alters spatial learning, motor activity, and anxiety in mice. J Neurosci. 2007;27(3):616–626. doi: 10.1523/JNEUROSCI.4464-06.2007
   PubMed Web of Science ®Google Scholar
• Botelho AFM, Pierezan F, Soto-Blanco B, et al. A review of cardiac glycosides: Structure, toxicokinetics, clinical signs, diagnosis and antineoplastic potential. Toxicon. 2019;158:63–68. doi: 10.1016/j.toxicon.2018.11.429
   PubMed Web of Science ®Google Scholar
• van Kanegan MJ, He DN, Dunn DE, et al. BDNF mediates neuroprotection against oxygen-glucose deprivation by the cardiac glycoside oleandrin. J Neurosci. 2014;34(3):963–968. doi: 10.1523/JNEUROSCI.2700-13.2014
   PubMed Web of Science ®Google Scholar
• Garofalo S, Grimaldi A, Chece G, et al. The glycoside oleandrin reduces glioma growth with direct and indirect effects on tumor cells. J Neurosci. 2017;37(14):3926–3939. doi: 10.1523/JNEUROSCI.2296-16.2017
   PubMed Web of Science ®Google Scholar
• Serafini S, de Freitas Souza C, Baldissera MD, et al. Fish exposed to water contaminated with eprinomectin show inhibition of the activities of AChE and Na+/K±ATPase in the brain, and changes in natural behavior. Chemosphere. 2019;223:124–130. doi: 10.1016/j.chemosphere.2019.02.026
   PubMed Web of Science ®Google Scholar
• Khordadmehr M, Nazifi S. Study of troponin, creatine kinase biomarkers, and histopathological lesions in experimental Nerium oleander toxicity in rats and mice. J Vet Res. 2018;62(1):97–102. doi: 10.2478/jvetres-2018-0013
   PubMed Web of Science ®Google Scholar
• Dinesh P, Rasool M. Herbal formulations and their bioactive components as dietary supplements for treating rheumatoid arthritis. Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases [Internet]; Elsevier. 2019 [cited 2023 Oct 20]. p. 385–399. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780128138205000222
   Google Scholar
• Liu R, Li X, Huang N, et al. Toxicity of traditional Chinese medicine herbal and mineral products. Advances in Pharmacology [Internet]. Elsevier; 2020 [cited 2023 Oct 20]. p. 301–346. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1054358919300638
   Google Scholar
• Ru Y, Luo Y, Zhou Y, et al. Adverse events associated with treatment of Tripterygium wilfordii Hook F: A quantitative evidence synthesis. Front Pharmacol. 2019;10:1250. doi: 10.3389/fphar.2019.01250
   PubMed Web of Science ®Google Scholar
• Chou W-C, Wu C-C, Yang P-C, et al. Hypovolemic shock and mortality after ingestion of tripterygium wilfordii hook F.: a case report. Int J Cardiol. 1995;49(2):173–177. doi: 10.1016/0167-5273(95)02282-2
   PubMed Web of Science ®Google Scholar
• Wu B-K, Yuan R-Y, Chang Y-P, et al. Epicatechin isolated from tripterygium wilfordii extract reduces tau-GFP-induced neurotoxicity in zebrafish embryo through the activation of Nrf2. Biochem Biophys Res Commun. 2016;477(2):283–289. doi: 10.1016/j.bbrc.2016.06.058
   PubMed Web of Science ®Google Scholar
• Xu Y, Li W, Wen R, et al. Voltage-gated sodium channels, potential targets of Tripterygium wilfordii Hook. f. to exert activity and produce toxicity. J Ethnopharmacol. 2023;311:116448. doi: 10.1016/j.jep.2023.116448
   PubMed Web of Science ®Google Scholar
• National Toxicology Program. Toxicity studies of Usnea lichens containing (±) Usnic acid (CASRN 125-46-2) administered in feed to F344/N NCTR Rats and B6C3F1/NCTR Mice. Natl Toxicol Program Tech Rep Ser. 2022:1–143.
   Google Scholar
• Crawford SD. Lichens used in Traditional Medicine. In: Ranković B, editor. Lichen Secondary Metabolites [Internet]. Cham: Springer International Publishing; 2015 [cited 2023 Oct 20]. p. 27–80. Available from: https://doi.org/10.1007/978-3-319-13374-4_2
   Google Scholar
• Kwong SP, Wang C. Review: Usnic acid-induced hepatotoxicity and cell death. Environ Toxicol Pharmacol. 2020;80:103493. doi: 10.1016/j.etap.2020.103493
   PubMed Web of Science ®Google Scholar
• Guo L, Shi Q, Fang J-L, et al. Review of usnic acid and Usnea Barbata Toxicity. J Environ Sci Health Part C. 2008;26(4):317–338. doi: 10.1080/10590500802533392
   Google Scholar
• Cazarin CA, Dalmagro AP, Gonçalves AE, et al. Usnic acid enantiomers restore cognitive deficits and neurochemical alterations induced by Aβ1–42 in mice. Behav Brain Res. 2021;397:112945. doi: 10.1016/j.bbr.2020.112945
   PubMed Web of Science ®Google Scholar
• Erfani S, Valadbeigi T, Aboutaleb N, et al. Usnic acid improves memory impairment after cerebral ischemia/reperfusion injuries by anti-neuroinflammatory, anti-oxidant, and anti-apoptotic properties. Iran J Basic Med Sci [Internet]. 2020 [cited 2023 Oct 20];23. doi: 10.22038/ijbms.2020.43280.10165
   PubMed Web of Science ®Google Scholar
• Lee S, Lee Y, Ha S, et al. Anti-inflammatory effects of usnic acid in an MPTP-induced mouse model of Parkinson’s disease. Brain Res. 2020;1730:146642. doi: 10.1016/j.brainres.2019.146642
   PubMed Web of Science ®Google Scholar
• Watts ME, Pocock R, Claudianos C. Brain energy and oxygen metabolism: Emerging role in normal function and disease. Front Mol Neurosci. 2018;11:216. doi: 10.3389/fnmol.2018.00216
   PubMed Web of Science ®Google Scholar
• Rabelo TK, Zeidán-Chuliá F, Vasques LM, et al. Redox characterization of usnic acid and its cytotoxic effect on human neuron-like cells (SH-SY5Y). Toxicol Vitro. 2012;26(2):304–314. doi: 10.1016/j.tiv.2011.12.003
   PubMed Web of Science ®Google Scholar
• Moreira CT, Oliveira AL, Comar JF, et al. Harmful effects of usnic acid on hepatic metabolism. Chem Biol Interact. 2013;203(2):502–511. doi: 10.1016/j.cbi.2013.02.001
   PubMed Web of Science ®Google Scholar
• EFSA Panel on Food Additives and Nutrient Sources Added to Food (ANS). Scientific Opinion on the evaluation of the safety in use of Yohimbe (Pausinystalia yohimbe (K. Schum.) Pierre ex Beille). EFS2 [Internet]. 2013 [cited 2023 Oct 19]. Available from: https://data.europa.eu/doi/10.2903/j.efsa.2013.3302
   Google Scholar
• Lo Faro AF, di Trana A, La Maida N, et al. Biomedical analysis of New Psychoactive Substances (NPS) of natural origin. J Pharm Biomed Anal. 2020;179:112945. doi: 10.1016/j.jpba.2019.112945
   PubMed Web of Science ®Google Scholar
• Clark JT, Smith ER, Davidson JM. Enhancement of sexual motivation in male rats by yohimbine. Science. 1984;225(4664):847–849. doi: 10.1126/science.6474156
   PubMed Web of Science ®Google Scholar
• Grunewald KK, Bailey RS. Commercially marketed supplements for bodybuilding athletes. Sports Med. 1993;15(2):90–103. doi: 10.2165/00007256-199315020-00003
   PubMed Web of Science ®Google Scholar
• Anderson C, Anderson D, Harre N, et al. Case study: two fatal case reports of acute yohimbine intoxication. J Anal Toxicol. 2013;37(8):611–614. doi: 10.1093/jat/bkt057
   PubMed Web of Science ®Google Scholar
• Scatton B, Zivkovic B, Dedek J. Antidopaminergic properties of yohimbine. J Pharmacol Exp Ther. 1980;215(2):494–499.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Yano S, Horiuchi H, et al. Ca2+ channel-blocking effect of the yohimbine derivatives, 14β-benzoyloxyyohimbine and 14β- p -nitrobenzoyloxyyohimbine. J Pharm and Pharmacol. 2011;39(6):439–443. doi: 10.1111/j.2042-7158.1987.tb03416.x
   Google Scholar
• Kleef Rgdm V, Embry MR, Mitchell CA, et al. Neuroactivity screening of botanical extracts using microelectrode array (MEA) recordings. Food Chem Toxicol. 2024;184:114438. doi: 10.1016/j.fct.2024.114438
   PubMed Web of Science ®Google Scholar